AVCN319302 / Avicanna, University of Toronto - LARVOL DELTA

Avicanna Files Complete Patent Specifications Relating to a Novel Cannabinoid Formulation for Reducing Incidence of Seizures and Sudden Unexpected Death in Epilepsy (Yahoo Finance) - "Avicanna Inc...is pleased to announce that it has formalized its provisional patent application, entitled 'Methods for Reducing or Eliminating Incidence of Seizures and Sudden Unexpected Death in Epilepsy', for the use of a novel cannabinoid formulation (the 'Formulation Candidate') after completion of in-vivo animal studies. The formal application is filed with WIPO by claiming the priority date of US provisional application filed in September 2022 using the Patent Co-operation Treaty (PCT) system."

Patent • CNS Disorders • Epilepsy

Avicanna Expands its Epilepsy Research Program with a New Collaboration with the University of Toronto (Yahoo Finance) - "Avicanna Inc...is pleased to announce that it has expanded its research collaboration in field of Epilepsy with a new collaboration with the University of Toronto and Dr. Mac Burnham’s research team to explore the efficacy of Avicanna’s proprietary formulations in pre-clinical models for Epilepsy....The research collaboration led by Dr. Mac Burnham’s team will explore the efficacy of Avicanna’s drug candidates including AVCN319302 in animal models for Epilepsy."

Licensing / partnership • CNS Disorders • Epilepsy